Improved Exercise Capacity and Ischemia 6 and 12 Months After Transendocardial Injection of Autologous Bone Marrow Mononuclear Cells for Ischemic Cardiomyopathy
- 14 September 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 110 (11_suppl_1), II-213-II-218
- https://doi.org/10.1161/01.cir.0000138398.77550.62
Abstract
Background— We recently reported the safety and feasibility of autologous bone marrow mononuclear cell (ABMMNC) injection into areas of ischemic myocardium in patients with end-stage ischemic cardiomyopathy. The present study evaluated the safety and efficacy of this therapy at 6- and 12-month follow-up.Keywords
This publication has 22 references indexed in Scilit:
- Diagnostic Accuracy and Prognostic Relevance of the Measurement of Cardiac Natriuretic Peptides: A ReviewClinical Chemistry, 2004
- Endothelial Progenitor CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart FailureCirculation, 2003
- Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth FactorsCirculation, 2003
- Transdifferentiation of Blood-Derived Human Adult Endothelial Progenitor Cells Into Functionally Active CardiomyocytesCirculation, 2003
- Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantationThe Lancet, 2003
- Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI)Circulation, 2002
- ACC/AHA 2002 guideline update for exercise testing: summary articleJournal of the American College of Cardiology, 2002
- Repair of Infarcted Myocardium by Autologous Intracoronary Mononuclear Bone Marrow Cell Transplantation in HumansCirculation, 2002
- Assessing Myocardial Viability and Infarct Transmurality With Left Ventricular Electromechanical Mapping in Patients With Stable Coronary Artery DiseaseCirculation, 2002